user

Familial risks of acute myeloid leukemia, myelodysplastic syndromes, and myeloproliferative neoplasms

被引：32
|
作者：
Sud, Amit [1 ,2 ]
Chattopadhyay, Subhayan [2 ]
Thomsen, Hauke [2 ]
Sundquist, Kristina [3 ,4 ,5 ]
Sundquist, Jan [3 ,4 ,5 ]
Houlston, Richard S. [1 ,6 ]
Hemminki, Kari [2 ,3 ]
机构：
[1] Inst Canc Res, Div Genet & Epidemiol, London, England
[2] German Canc Res Ctr, Div Mol Genet Epidemiol, Heidelberg, Germany
[3] Lund Univ, Ctr Primary Hlth Care Res, Malmo, Sweden
[4] Icahn Sch Med Mt Sinai, Dept Populat Hlth Sci & Policy, Dept Family Med & Community Hlth, New York, NY 10029 USA
[5] Shimane Univ, Sch Med, Dept Funct Pathol, Ctr Community Based Healthcare Res & Educ, Matsue, Shimane, Japan
[6] Inst Canc Res, Div Mol Pathol, London, England
来源：
BLOOD | 2018年 / 132卷 / 09期
基金：
瑞典研究理事会;
关键词：
DISEASE ANTICIPATION; POLYCYTHEMIA-VERA; CANCER DATABASE; GERM-LINE; VARIANTS; JAK2;
D O I：
10.1182/blood-2018-06-858597
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：973 / 976
页数：4
相关论文
共 50 条
  • [21] The Challenge of Treating Myelodysplastic Syndromes/Myeloproliferative Neoplasms
    Ragon, Brittany Knick
    Savona, Michael R.
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 : S37 - S42
  • [22] Myelodysplastic and myeloproliferative neoplasms: updates on the overlap syndromes
    Thota, Swapna
    Gerds, Aaron T.
    [J]. LEUKEMIA & LYMPHOMA, 2018, 59 (04) : 803 - 812
  • [23] Combination of treosulfan, fludarabine and cytarabine as conditioning in patients with acute myeloid leukemia, myelodysplastic syndrome and myeloproliferative neoplasms
    Samantha O‘Hagan Henderson
    Jochen J. Frietsch
    Inken Hilgendorf
    Andreas Hochhaus
    Claus-Henning Köhne
    Jochen Casper
    [J]. Journal of Cancer Research and Clinical Oncology, 2022, 148 : 2599 - 2609
  • [24] Epidemiology of myeloproliferative neoplasms and myelodysplastic syndromes in Germany
    Kraywinkel, Klaus
    [J]. ONKOLOGE, 2019, 25 (11): : 948 - 956
  • [25] Combination of treosulfan, fludarabine and cytarabine as conditioning in patients with acute myeloid leukemia, myelodysplastic syndrome and myeloproliferative neoplasms
    O'Hagan Henderson, Samantha
    Frietsch, Jochen J.
    Hilgendorf, Inken
    Hochhaus, Andreas
    Koehne, Claus-Henning
    Casper, Jochen
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2022, 148 (10) : 2599 - 2609
  • [26] MOLECULAR ALTERATIONS ASSOCIATED WITH PROGRESSION OF MYELODYSPLASTIC SYNDROMES TO MYELODYSPLASTIC SYNDROMES/MYELOPROLIFERATIVE NEOPLASMS
    Valencia, A.
    Masala, E.
    Buchi, F.
    Sanna, A.
    Gozzini, A.
    Contini, E.
    Torricelli, F.
    Przychodzen, B.
    Maciejewski, J. P.
    Bosi, A.
    Santini, V.
    [J]. HAEMATOLOGICA, 2015, 100 : 54 - 54
  • [27] Acute Myeloid Leukemia Arising from Myelodysplastic Syndromes
    Kwon, Adelaide
    Weinberg, Olga K.
    [J]. CLINICS IN LABORATORY MEDICINE, 2023, 43 (04) : 657 - 667
  • [28] Acute myeloid leukemia and myelodysplastic syndromes in older patients
    Estey, Elihu
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (14) : 1908 - 1915
  • [29] Epigenetic therapy of myelodysplastic syndromes and acute myeloid leukemia
    Voso, Maria Teresa
    Lo-Coco, Francesco
    Fianchi, Luana
    [J]. CURRENT OPINION IN ONCOLOGY, 2015, 27 (06) : 532 - 539
  • [30] Immune Therapies for Myelodysplastic Syndromes and Acute Myeloid Leukemia
    Kapoor, Sargam
    Champion, Grace
    Basu, Aparna
    Mariampillai, Anu
    Olnes, Matthew J.
    [J]. CANCERS, 2021, 13 (19)
12345